Trials / Completed
CompletedNCT02535520
Evaluation of RTVue XR With SSADA
Clinical Evaluation of RTVue XR With SSADA in Retinal Patients
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 155 (actual)
- Sponsor
- Optovue · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Optovue has implemented a motion contrast imaging software in RTVue XR, a split spectrum amplitude decorrelation algorithm (SSADA), for non-invasive imaging of ocular vasculature. Consented subjects will undergo a series of images of the back of the eye using an Optical Coherence Tomograpy (OCT) device, RTVue XR, in addition to the conventional images as part of clinical routine. SSADA images will be compared with conventional methods.
Conditions
Timeline
- Start date
- 2015-08-01
- Primary completion
- 2015-10-01
- Completion
- 2015-12-01
- First posted
- 2015-08-28
- Last updated
- 2016-03-30
Source: ClinicalTrials.gov record NCT02535520. Inclusion in this directory is not an endorsement.